Edition:
United Kingdom

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

1.62USD
21 Aug 2018
Change (% chg)

$0.04 (+2.53%)
Prev Close
$1.58
Open
$1.60
Day's High
$1.65
Day's Low
$1.58
Volume
65,612
Avg. Vol
46,249
52-wk High
$2.58
52-wk Low
$0.97

Chart for

About

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company's product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that... (more)

Overall

Beta: 3.06
Market Cap(Mil.): $103.29
Shares Outstanding(Mil.): 67.07
Dividend: --
Yield (%): --

Financials

  EYES.OQ Industry Sector
P/E (TTM): -- 37.42 30.39
EPS (TTM): -0.54 -- --
ROI: -251.23 14.28 12.61
ROE: -251.23 17.48 14.80

BRIEF-Second Sight Completes $10 Mln Private Placement Of Common Stock With Chairman Of Board Of Directors

* SECOND SIGHT COMPLETES $10 MILLION PRIVATE PLACEMENT OF COMMON STOCK WITH GREGG WILLIAMS, CHAIRMAN OF THE BOARD OF DIRECTORS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

07 May 2018

BRIEF-Second Sight Medical Products Says Robert Greenberg's Resignation "Was An Outgrowth Of A Disagreement Over His Reporting Relationship" With Co

* FORMER CHAIMAN ROBERT GREENBERG'S RESIGNATION "WAS AN OUTGROWTH OF A DISAGREEMENT OVER HIS REPORTING RELATIONSHIP" WITH CO

09 Apr 2018

BRIEF-Second Sight Appoints John Blake Chief Financial Officer

* SECOND SIGHT APPOINTS JOHN T. BLAKE CHIEF FINANCIAL OFFICER

22 Mar 2018

BRIEF-Second Sight Appoints Gregg Williams As Chairman Of The Board Of Directors

* SECOND SIGHT APPOINTS GREGG WILLIAMS AS CHAIRMAN OF THE BOARD OF DIRECTORS

16 Mar 2018

BRIEF-Second Sight Q4 Loss Per Share $0.13

* SECOND SIGHT REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

07 Mar 2018

Earnings vs. Estimates